Recently, CD26 (dipeptidyl-peptidase IV) has been identified as a specific CML LSC marker, as it is consistently expressed in chronic-phase CML patients but not in normal HSCs or stem cells of other (myeloid) neoplasms [30]. This evidence concerns the gene DPP4 and chronic myelogenous leukemia, BCR-ABL1 positive.